UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q/A
(Amendment No. 1)
| |
|
|
| x |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2007
OR
| |
|
|
| o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934 |
For the transition period from _________to _________
Commission file number 0-15327
CYTRX CORPORATION
(Exact name of Registrant as specified in its charter)
| |
|
|
| Delaware
|
|
58-1642740 |
(State or other jurisdiction
of incorporation or organization)
|
|
(I.R.S. Employer Identification No.) |
| |
|
|
11726 San Vicente Blvd.
Suite 650
Los Angeles, CA
(Address of principal executive offices)
|
|
90049
(Zip Code) |
(310) 826-5648
(Registrant’s telephone number, including area code)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the Registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes x No o
Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule
12(b)-2 of the Exchange Act).
Yes x No o
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12(b)-2 of the
Exchange Act).
Yes o No þ
Number of shares of CytRx Corporation Common Stock, $.001 par value, issued and outstanding as
of May 7, 2007: 86,813,178, exclusive of treasury shares.
PART II — OTHER INFORMATION
Item 6. — Exhibits
The exhibits listed in the accompanying Index to Exhibits are filed as part of this Form
10-Q/A.
2